(NASDAQ: DXCM) Dexcom's forecast annual revenue growth rate of 17.89% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.16%.
Dexcom's revenue in 2024 is $3,622,300,000.On average, 9 Wall Street analysts forecast DXCM's revenue for 2024 to be $1,664,652,503,755, with the lowest DXCM revenue forecast at $1,646,420,708,465, and the highest DXCM revenue forecast at $1,680,847,235,560. On average, 9 Wall Street analysts forecast DXCM's revenue for 2025 to be $1,982,291,766,641, with the lowest DXCM revenue forecast at $1,925,250,904,950, and the highest DXCM revenue forecast at $2,028,427,939,134.
In 2026, DXCM is forecast to generate $2,284,901,325,324 in revenue, with the lowest revenue forecast at $1,961,772,322,843 and the highest revenue forecast at $2,412,555,504,618.